CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Wedbush Adjusts Pt on Edgewise Therapeutics to $53 From $52, Maintains Outperform Rating

Neutral
AI Analysis

Summary

Wedbush adjusted its price target on Edgewise Therapeutics from $52 to $53 while maintaining an Outperform rating.

Importance:2/10
Sentiment:
0.10
price_targetanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on August 7, 2026 10:08 AM

Read Original